SummaryAims The aim of this study was to assess cardiovascular (CV) safety of testosterone replacement therapy (TRT) in a large, diverse cohort of European men with hypogonadism (HG). Methods The Registry of Hypogonadism in Men (RHYME) was designed as a multi-national, longitudinal disease registry of men diagnosed with hypogonadism (HG) at 25 clinical sites in six European countries. Data collection included a complete medical history, physical examination, blood sampling and patient questionnaires at multiple study visits over 2–3 years. Independent adjudication was performed on all mortalities and CV outcomes. Results Of 999 patients enrolled with clinically diagnosed HG, 750 (75%) initiated some form of TRT. Registry participan...
The cardiovascular (CV) benefit and safety of treating low testosterone conditions is a matter of de...
AbstractThe relationship between testosterone deficiency syndrome (TDS) and men's vascular health ha...
OBJECTIVE: Investigate the impact of testosterone replacement therapy (TRT) on cardiovascular outcom...
SummaryAims The aim of this study was to assess cardiovascular (CV) safety of testosterone replacem...
Aims: The aim of this study was to assess cardiovascular (CV) safety of testosterone replacement the...
Background: Testosterone is the standard treatment for male hypogonadism, but there is uncertainty a...
Background Testosterone is the standard treatment for male hypogonadism, but there is uncertainty ab...
Endogenous testosterone levels are inversely associated with cardiovascular risk in older men and me...
The numbers of testosterone prescriptions written have increased several-fold worldwide, but the inc...
Abstract The relationship between testosterone deficiency syndrome (TDS) and men's vascular health h...
Background: Concerns have been expressed over the safety of testosterone replacement therapy (TRT) i...
Objective: Testosterone therapy (TTh) may reduce morbidity/mortality in men with adult-onset testost...
Background Testosterone therapy is increasingly promoted. No randomized placebo-controlled trial has...
Ahmad Haider,1 Aksam Yassin,2-4 Karim Sultan Haider,1 Gheorghe Doros,5 Farid Saad,4,6 Giuseppe MC Ro...
Background Testosterone therapy is increasingly promoted. No randomized placebo-controlled trial has...
The cardiovascular (CV) benefit and safety of treating low testosterone conditions is a matter of de...
AbstractThe relationship between testosterone deficiency syndrome (TDS) and men's vascular health ha...
OBJECTIVE: Investigate the impact of testosterone replacement therapy (TRT) on cardiovascular outcom...
SummaryAims The aim of this study was to assess cardiovascular (CV) safety of testosterone replacem...
Aims: The aim of this study was to assess cardiovascular (CV) safety of testosterone replacement the...
Background: Testosterone is the standard treatment for male hypogonadism, but there is uncertainty a...
Background Testosterone is the standard treatment for male hypogonadism, but there is uncertainty ab...
Endogenous testosterone levels are inversely associated with cardiovascular risk in older men and me...
The numbers of testosterone prescriptions written have increased several-fold worldwide, but the inc...
Abstract The relationship between testosterone deficiency syndrome (TDS) and men's vascular health h...
Background: Concerns have been expressed over the safety of testosterone replacement therapy (TRT) i...
Objective: Testosterone therapy (TTh) may reduce morbidity/mortality in men with adult-onset testost...
Background Testosterone therapy is increasingly promoted. No randomized placebo-controlled trial has...
Ahmad Haider,1 Aksam Yassin,2-4 Karim Sultan Haider,1 Gheorghe Doros,5 Farid Saad,4,6 Giuseppe MC Ro...
Background Testosterone therapy is increasingly promoted. No randomized placebo-controlled trial has...
The cardiovascular (CV) benefit and safety of treating low testosterone conditions is a matter of de...
AbstractThe relationship between testosterone deficiency syndrome (TDS) and men's vascular health ha...
OBJECTIVE: Investigate the impact of testosterone replacement therapy (TRT) on cardiovascular outcom...